Reticulosarcomatosis (type Gottron)
Knickenberg, M.; Hornstein, O.P.
Zeitschrift für Hautkrankheiten 50(19): 825-827
1975
ISSN/ISBN: 0301-0481 PMID: 1106011 Document Number: 84536
Document emailed within 1 workday
Related Documents
Runne, U. 1975: Acute myeloid monocytic leukemia with multiple cutaneous nodes simulating the so-called reticulosarcomatosis cutis Gottron Zeitschrift für Hautkrankheiten 50(19): 816-817Blaszczyk, M.; Depaepe, A.; Nuytinck, L.; Glinska-Ferenz, M.; Jablonska, S. 2000: Acrogeria of the Gottron type in a mother and son European Journal of Dermatology: Ejd 10(1): 36-40
Bakhtiiarov, V.A. 1974: Reticulosarcomatosis of the small intestine Klinicheskaia Khirurgiia 10: 44-45
Karalitskiĭ, E.M. 1981: Arndt-Gottron scleromyxedema Vestnik Dermatologii i Venerologii 7: 41-44
Bergol'ts, V.M.; Moskovkina, O.Ia.; Sokolov, P.P.; Sukhin, G.M.; Kondrat'eva, I.A. 1974: Humoral immunity in viral reticulosarcomatosis in mice Voprosy Onkologii 20(11): 35-39
Patakfalvi, A.; Simon, K.; Horváth, T.; Böhm, G. 1971: Quantitative immunoglobulin determination in paraproteinemias, lymphogranulomatosis and lympho-reticulosarcomatosis Orvosi Hetilap 112(2): 75-78
Günther, H.M.; Sitzmann, F. 1978: The Gottron syndrome from the dentist's viewpoint, case report Deutsche Zahnarztliche Zeitschrift 33(12): 873-875
Korting, G.W.; Gottron HA|GOTTRON, H.A. 1974: In memory of Adolf Heinrich Gottron, 3, 10, 1890 to 6, 23, 1974 Deutsche Medizinische Wochenschrift 99(39): 1940-1942
Schirren, C.G.; Betke, M.; Eckert, F.; Przybilla, B. 1992: Arndt-Gottron scleromyxedema. Case report and review of therapeutic possibilities Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 43(3): 152-157
Kalamkarian, A.A. 1988: Principles of the current therapy of malignant lymphomas of the skin (mycosis fungoides, primary reticulosis, reticulosarcomatosis of the skin) and Kaposi's sarcoma Vestnik Dermatologii i Venerologii 2: 4-10
Mast, T.Christopher.; Kierstead, L.; Gupta, S.B.; Nikas, A.A.; Kallas, E.G.; Novitsky, V.; Mbewe, B.; Pitisuttithum, P.; Schechter, M.; Vardas, E.; Wolfe, N.D.; Aste-Amezaga, M.; Casimiro, D.R.; Coplan, P.; Straus, W.L.; Shiver, J.W. 2010: International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials Vaccine 28(4): 950-957
McKean, D.J.; Podzorski, R.P.; Bell, M.P.; Nilson, A.E.; Huntoon, C.J.; Slack, J.; Dower, S.K.; Sims, J. 1993: Murine T helper cell-2 lymphocytes express type I and type II IL-1 receptors, but only the type I receptor mediates costimulatory activity Journal of Immunology 151(7): 3500-3510
Antonaci, S.; Jirillo, E.; Garofalo, A.R.; Polignano, A.; Resta, F.; Pugliese, P.; Capurso, A.; Bonomo, L. 1988: Cell-mediated immune response in patients with type IIa, type IIb and type IV primary hyperlipoproteinaemia Cytobios 54(218-219): 181-189
Berntorp, E.; Jarevi, G.; Vedback, A.; Nilsson, I.M. 1986: Living adenovirus type 4 vaccine human t lymphotropic virus type iii antibodies in swedish hemophiliacs in relation to type and dosage of factor concentrate Thrombosis Research (Suppl 6): 18
Rathore, A.; Chatterjee, A.; Sivarama, P.; Yamamoto, N.; Singhal, P.K.; Dhole, T.N. 2009: Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians Aids Research and Human Retroviruses 25(11): 1149-1156
Su, Z.Z.; Leon, J.A.; Jiang, H.; Austin, V.N.; Zimmer, S.G.; Fisher, P.B. 1993: Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells Cancer Research 53(8): 1929-1938
Rao, T.V.; Koul, R.L.; Inuwa, I.M. 2005: Congenital fiber-type disproportion myopathy with type i fiber predominance and type Ii fiber smallness and atrophy--a sterological analysis Clinical Neuropathology 24(1): 26-31
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
DeWitt, D.E.; Hirsch, I.B. 2003: Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review JAMA 289(17): 2254-2264